Researchers from the University of Copenhagen and the Psychiatric Center Copenhagen have uncovered the cellular and synaptic effects of the drug VU-0364572, a selective modulator of the M1 muscarinic ...

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol. 1997 Apr;54(4):465-73. PubMed. Hemstapat K, Da Costa H, ...

Vanderbilt University has synthesized muscarinic M4 receptor positive allosteric modulators (PAMs) reported to be useful for the treatment of Alzheimer’s disease, pain, schizophrenia and sleep ...